Tropical Parasitology

ORIGINAL ARTICLE
Year
: 2022  |  Volume : 12  |  Issue : 2  |  Page : 78--86

In vitro antiplasmodial activity of selected plants from the Colombian North Coast with low cytotoxicity


Saray Vergara1, Fredyc Diaz2, Amalia Diez3, Josť M Bautista3, Carlos Moneriz4,  
1 Biochemistry and Disease Group, Faculty of Medicine, University of Cartagena; Genome Research Group, Faculty of Health, University of Sinu Elias Bechara Zainum - Cartagena Sectional, Cartagena, Colombia
2 Phytochemical and Pharmacological Research Laboratory, University of Cartagena, Cartagena, Colombia
3 Department of Biochemistry and Molecular Biology IV, Complutense University of Madrid, Ciudad Universitaria, Madrid, Spain
4 Biochemistry and Disease Group, Faculty of Medicine, University of Cartagena, Cartagena, Colombia

Correspondence Address:
Carlos Moneriz
Biochemistry and Diseases Research Group, Faculty of Medicine, University of Cartagena, Zaragocilla Campus, Cartagena - 130 015
Colombia

Abstract

Background: Plants are an important option in the treatment of malaria, especially in endemic regions, and are a less expensive and more accessible alternative with a lower risk of toxicity. Colombia has a great diversity of plants, and evaluation of natural extracts could result in the discovery of new compounds for the development of antimalarial drugs. The purpose of this work was to evaluate the in vitro antiplasmodial activity and the cytotoxicity of plant extracts from the Colombian North Coast against Plasmodium falciparum. Materials and Methods: The antiplasmodial activity of 12 plant species from the Colombian North Coast that are used in traditional medicine was evaluated through in vitro cultures of P. falciparum, and the cytotoxicity of extracts of these species to human cells was determined. Plant extracts with high antiplasmodial activity were subjected to preliminary phytochemical screening. Results: Extracts from five plants had promising antiplasmodial activity. Specifically, Bursera simaruba (Burseraceae) (bark), Guazuma ulmifolia Lam. (Malvaceae) (whole plant), Murraya exotica L. (Rutaceae) (leaves), Hippomane mancinella L. (Euphorbiaceae) (seeds), and Capparis odoratissima Jacq. (Capparaceae) (leaves). Extracts presented 50% inhibitory concentration values between 1 and 9 μg/ml. Compared to no extract, these active plant extracts did not show cytotoxic effects on mononuclear cells or hemolytic activity in healthy human erythrocytes. Conclusions: The results obtained from this in vitro study of antiplasmodial activity suggest that active plant extracts from the Colombian North Coast are promising for future bioassay-guided fractionation to allow the isolation of active compounds and to elucidate their mechanism of action against Plasmodium spp.



How to cite this article:
Vergara S, Diaz F, Diez A, Bautista JM, Moneriz C. In vitro antiplasmodial activity of selected plants from the Colombian North Coast with low cytotoxicity.Trop Parasitol 2022;12:78-86


How to cite this URL:
Vergara S, Diaz F, Diez A, Bautista JM, Moneriz C. In vitro antiplasmodial activity of selected plants from the Colombian North Coast with low cytotoxicity. Trop Parasitol [serial online] 2022 [cited 2023 Feb 9 ];12:78-86
Available from: https://www.tropicalparasitology.org/text.asp?2022/12/2/78/361961


Full Text



 Introduction



Approximately 80% of the world's population depends on drugs extracted from plants for their basic health needs. Compounds derived from plants have been central in the development of antimalarial treatments, and two such compounds emerged from South America. Quinine, an active ingredient from the bark of the Cinchona tree, became the first compound with antimalarial activity and led to the design of chloroquine, one of the most widely used antimalarial agents until recently.[1]

Likewise, lapachol, a naphthoquinone used in the 19th century for the treatment of fever in South America, was isolated for the first time from Tabebuia avellanedae Lorentz ex Griseb. (Bignoniaceae). Later, after chemical optimization, atovaquone was obtained, and it is currently used in association with proguanil for malaria prophylaxis and treatment.[2],[3]

Traditional remedies are an integral part of Colombian culture. Various studies of the ethnopharmacology and use of popular medicine among the population of the Atlantic Coast of Colombia, specifically in the state of Bolívar, have reported many perspectives in the search for new drugs based on local uses of medicinal plants.[4]

To date, there is no registered and effective vaccine that can be applied to the population as a preventive measure to control or eradicate malaria. Therefore, chemotherapy continues to be the main measure to combat the disease, and due to increasing drug resistance, the discovery of new therapeutic options is necessary.[5]

In this work, the in vitro antiplasmodial activity of 12 plants from the Colombian North Coast used in traditional medicine was evaluated. The results obtained from this study suggest that the extracts tested are promising for future biodirected assays that could allow the isolation of active compounds to further unravel their mechanism of action against Plasmodium.

 Materials and Methods



Selection and collection of plant material

Plant species from the North Coast of Colombia used as traditional medicine were studied.[4],[6] Twelve species were selected via a bibliographic database review in which they had no or few previous reports of antimalarial activity [Table 1]. Voucher specimens were collected and numbered during the interviews, with prior permission obtained by the University of Cartagena through the regional autonomous corporation of Canal Del Dique. Specimen identification was carried out by comparison with authentic samples. The vouchers were deposited in the botanical garden in Cartagena and the Herbarium of the National University of Colombia (COL).{Table 1}

Preparation of plant extracts

Vegetable samples were dried for 2 days at 40°C in an oven with air circulation. After this period, the plant material was ground by mechanical methods using a blade mill. Extracts of the different organs of the plants were obtained by continuous maceration of 100 g of pulverized material in 96% ethanol (relation 1:4 of plant material) at 25°C, as previously described in other studies.[7] The extraction was repeated until the plant material was exhausted; after this time, the extracts were filtered and concentrated under reduced pressure in a rotary evaporator. Finally, after weighing, the obtained extracts were dissolved with the smallest possible volume of dimethyl sulfoxide (DMSO) and then diluted as required in culture medium (RPMI 1640) to prepare different concentrations of the extracts for biological assays. The final DMSO concentration was never >0.05% to avoid carry-over (solvent) effects.[8]

In vitro culture of Plasmodium falciparum

Two different strains of Plasmodium falciparum were used, the chloroquine sensitive (3D7) and chloroquine resistant (Dd2). A detailed description of the culture and synchronization methods used has been reported previously.[9]

In vitro antiplasmodial activity of the plant extracts

A microfluorimetric DNA-based assay was used to monitor P. falciparum (strain 3D7 and Dd2) growth inhibition at different concentrations of the plant extracts.[10] Synchronized rings from stock cultures were used to test serial dilutions of plant extracts (100 μg/mL to 0.01 μg/mL) in 96-well culture microplates to obtain 2% hematocrit and 1% parasitemia. Subsequently, the parasite was allowed to grow for 48 h in 5% CO2 at 37°C. After incubation, the microplates were centrifuged at 600 × g for 10 min, and the contents were resuspended in saponin (0.15%, w/v in phosphate-buffered saline [PBS]) to lyse the erythrocytes and release the malaria parasites. To eliminate all traces of hemoglobin, the pellet was washed by the addition of 200 μL of PBS followed by centrifugation at 600 × g. The washing step was repeated twice to ensure the complete removal of hemoglobin. Finally, the pellets were resuspended in 100 μL of PBS and mixed with 100 μL of PicoGreen (Invitrogen-P7589).[11] Plates were incubated for 30–60 min in the dark, and the fluorescence intensity was measured at 485-nm excitation and 528-nm emission. Each test also included an untreated control, and chloroquine was used as the reference drug. Growth inhibition was calculated as previously described.[10] Three independent experiments were performed in triplicate to determine the antiplasmodial activity of each extract. The 50% inhibitory concentration (IC50) values of plant extracts against Plasmodium growth were determined using SigmaPlot software.

In vitro cytotoxicity test of the plant extracts on human peripheral blood mononuclear cells

The cytotoxic activity of plant extracts against human peripheral blood mononuclear cells (PBMCs) was evaluated by the trypan blue dye exclusion method.[12] The dye exclusion test was used to determine the number of viable cells present in a cell suspension. These cells were obtained from the blood of healthy donors using Histopaque (Sigma-Aldrich-1077). A total of 6 × 105 cells per well were mixed in triplicate for each tested concentration of the plant extracts (range: 1000–0.01 μg/mL) and controls in RPMI 1640 supplemented with 10% fetal bovine serum and 1% penicillin-streptomycin for a total volume of 200 μL in 96-well microplates. Cells were immediately incubated for 48 h at 37°C in a humid atmosphere with 5% CO2.[13] At the end of incubation, 100 μL of trypan blue dye was added to 100 μL of cell suspension. Then, viable cells were counted for each replicate at each extract concentration and for the controls. Three independent experiments were performed in triplicate to determine the cytotoxicity of each extract. The 50% lethal concentration (LC50) values of the plant extracts in PBMCs were determined using SigmaPlot software.

Hemolysis assay of plant extracts

The potential hemolytic effects of those plant extracts with promising antiplasmodial activity were investigated by incubating them with healthy human erythrocytes in 96-well microplates and determining the absorbance at 540 nm, which corresponds to the released hemoglobin in the supernatants.

For these tests, erythrocytes at 2% hematocrit were incubated with different concentrations of the plant extracts (1–100 μg/mL). A 2% hematocrit control solution was prepared in distilled water (100% relative hemolysis) as previously described.[14] The results are expressed as a percentage of relative hemolysis compared to that of the 100% hemolysis control.

Morphology of the Plasmodium falciparum cultures after treatment with the plant extracts

The morphologies of the parasites (P. falciparum strain Dd2) from each culture at different concentrations of the plant extracts (described in the previous section) were evaluated by microscopic analysis of thin blood smears stained with Wright's stain after incubation. Stage-specific development was assessed by examining a minimum of 1000 parasitized cells on each smear for the differential counting of rings, trophozoites, schizonts, and pyknotic forms whose developmental stages could not be established. The fraction in each group was calculated as a percentage of the total parasitized cells. Parasitemia was measured by counting 1000 red cells and is reported as the percent of parasitized erythrocytes.[15] Smears from plant extract-free cultures were used as a control.

Phytochemical screening

Plant extracts with favorable antiplasmodial activity were subjected to a preliminary phytochemical screen in order to detect the presence (or absence) of alkaloids, flavonoids, tannins, coumarins, saponins, triterpenes, sterols, quinones, and cardiac glycosides, as previously described in other studies.[16]

 Results



In vitro antiplasmodial and cytotoxic activity of the plant extracts studied

The in vitro antiplasmodial activity of 12 plant extracts from the North Coast of Colombia was evaluated for the 3D7 and Dd2 strains of P. falciparum. The results are described in detail in [Table 2].{Table 2}

According to the WHO guidelines, antiplasmodial activity is classified as follows: high activity at IC50 <5 μg/mL, good activity at 5–10 μg/mL, moderate activity at 11–50 μg/mL, and inactive at >50 μg/mL.[17],[18]

The selectivity index (SI) of each extract is also presented in [Table 2]. The SI is defined as the ratio of the LC50 value in PBMCs to the IC50 value against P. falciparum.[8]

These results highlighted five extracts with high to good antiplasmodial activity [Table 2]: B. simaruba (bark), G. ulmifolia (whole plant), M. exotica (leaves), H. mancinella (seeds), and Capparis odoratissima (leaves).

Human PBMCs exhibited high survival rates when exposed to the extracts at 100–0.01 μg/mL. The LC50 values were above 100 μg/mL and much higher than the IC50 values against P. falciparum, indicating lower cytotoxicity than the control without treatment. The SI of the plant extracts was assessed and demonstrated specific antiplasmodial activity rather than toxicity to PBMCs since most of the indices were ≥2.

Hemolytic effects of the active plant extracts

To evaluate the effects of the active extracts on the structural integrity of erythrocytes, the hemoglobin concentration was determined in samples of red blood cells incubated with each extract with high antiplasmodial activity (B. simaruba, G. ulmifolia, M. exotica, H. mancinella, and C. odoratissima) for 48 h at 37°C. Compared with the control treatment without extract, none of the extract treatments showed hemolytic activity against healthy erythrocytes, as shown in [Table 3], which suggests low toxicity for the extracts against erythrocytes.{Table 3}

Phenotypic effects of the active plant extracts on the intraerythrocytic stages of Plasmodium falciparum

The effects on the morphology of the intraerythrocytic stages of the parasite (P. falciparum strain Dd2) were determined by microscopic visualization of smears from sediments of the microcultures exposed to 100, 10, and 1 μg/mL active plant extracts. In this analysis, we found variations in the proportion of P. falciparum forms compared to that of the untreated control [Figure 1]. Pyknotic forms, a morphological sign of cell death consisting of the retraction of the nucleus with condensation of the parasite's chromatin in the form of a solid mass, were frequently observed at all three concentrations of the five active extracts studied [Figure 2].{Figure 1}{Figure 2}

Other modifications to the structures of the parasitic stages, specifically alterations in the normal shape of the rings, were observed, such as dysmorphism, delayed maturation of trophozoites, and the presence of forms with an increased size of the parasitophorous vacuole [Figure 1] and [Figure 2]. These morphological alterations were seen more frequently at 10 and 1 μg/mL [Figure 1] and [Figure 2]. Chloroquine treatment did not generate these alterations [Figure 1] and [Figure 2]. Accordingly, we suggest that the active extracts inhibit the maturation of the parasite.

On the other hand, the percentage of rings decreased at higher concentrations of the active plant extracts, suggesting that these extracts inhibited the invasive cycle of the parasite; moreover, in all extracts, a low percentage of schizonts was observed at the three concentrations tested [Figure 1]. All these morphological alterations indicate that these active extracts, when tested at concentrations close to their IC50 values, cause important phenotypic changes during the parasite life cycle.

Phytochemical screening

Chemical identification tests were applied to the extracts of the selected species that displayed antiplasmodial activity, and they show the presence of several families of secondary metabolites. [Table 4] shows the results of this phytochemical screen.{Table 4}

 Discussion



The acceleration of the increase in the resistance of parasites against available antimalarial drugs has become one of the greatest difficulties for the control and eradication of malaria. The development of new therapeutic alternatives that meet the requirements of rapid efficacy, minimal toxicity, and low cost is essential and in great need worldwide to counteract this disease.[19] Primary screenings for the antimalarial activity of plant species can generate basic information that allows the selection of potential extracts and determination of their composition of secondary metabolites and biological activity against the parasites.[20]

In this study, five plant extracts were found to have promising activity in inhibiting the development of P. falciparum in vitro. The selected species are representative of the Colombian North Coast and are used in traditional medicine in the region; these species have been part of a chemical study to identify secondary metabolites, and to date, there are few reports on their actions as antimalarial plants [Table 5].{Table 5}

The five species that were active for antiplasmodial activity were B. simaruba (bark), G. ulmifolia (whole plant), M. exotica (leaves), H. mancinella (seeds), and C. odoratissima (leaves), which presented IC50 values <10 μg/mL for the 3D7 and Dd2 strains of P. falciparum. The IC50 values were always similar for both strains. Chloroquine exhibited an IC50 of 0.05 μg/mL against strain Dd2 (chloroquine resistant) and 0.007 μg/mL against strain 3D7 (chloroquine sensitive). The comparable IC50 values for active plant extracts found in chloroquine-resistant and sensitive strains suggest that these extracts may affect plasmodial processes different to those targeted by chloroquine. The extract of B. simaruba stands out with the lowest IC50 value of 1.2 μg/mL for the Dd2 strain and 1.7 μg/mL for the 3D7 strain.

The phenotypic effects of the five active extracts on the intraerythrocytic stages of P. falciparum strain Dd2 generated mostly the presence of the pyknotic form of the parasite at the maximum concentration tested and a small proportion of the ring forms and schizonts during the incubation period, which indicates that the parasite is not capable of completing the intraerythrocytic cycle, which probably affects the invasive stage of new erythrocytes. At concentrations close to the IC50 values of the active extracts, there were modifications to the structure of the parasitic form, such as delayed maturation of trophozoites and stages with a larger parasitophorous vacuole. These alterations have already been associated with compounds with powerful antimalarial activity.[36]

The alterations observed in the stages of the parasite incubated with the active plant extracts suggest that they could share similar mechanisms of action, possibly due to the common presence of secondary metabolites such as alkaloids and triterpenes/steroids. This hypothesis might be supported by a previous research, e.g., ten triterpenoid compounds with antimalarial activity (IC50 of 6–7 μM) were isolated and tested against Plasmodium berghei in murine models.[37]

Previous studies based on using trophozoite maturation delays to slow the invasive cycle of infection suggested that this response could be a consequence of inhibition of parasite proteases and phosphatases, according to the activity of maslinic acid and other related triterpenoid molecules, where a parasitostatic effect was suggested.[15] On the other hand, the presence of alkaloids in all of the active extracts tested is also notable. In previous reports,[38] guanidine-type alkaloids exhibited a broad bioactivity profile, especially as enzyme inhibitors.

We cannot finally discard that the compounds present in these active plant extracts may also act by blocking essential enzymatic pathways for the development of the erythrocyte cycle of the parasite, compromising survival. Consequently, the results of this screening suggest further pursuing fractionation and biological activity tests to isolate the active compounds responsible for this promising inhibition of P. falciparum and to determine their mechanism of action.

 Conclusions



This study on the in vitro antiplasmodial activity and cytotoxicity of the B. simaruba (bark), G. ulmifolia (whole plant), M. exotica (leaves), H. mancinella (seeds), and C. odoratissima (leaves) extracts showed their inhibitory effect on P. falciparum growth with nearly negligible cytotoxic effects and no hemolytic damage. Thus, those extracts should contain active molecules responsible for such biological effects on the malaria parasite, which supports future bioassay-guided fractionation to identify the specific compounds to test their activity and unravel their mechanisms of action against P. falciparum in the potential discovery of new compounds for the development of antimalarial drugs.

Ethical clearance

The ethical and scientific procedures of this study were certified by the Ethics Committee of the Faculty of Medicine, University of Cartagena, Colombia (study number 80/5-03-2015).

Highlights

Extracts from five Colombian plants had promising antiplasmodial activityActive plant extracts did not show cytotoxic effects on human cellsPyknotic forms and alterations in trophozoites were observed in the active extractsThe extract of Bursera simaruba stands out with the lowest 50% inhibitory concentration (IC50) valueAlkaloids and triterpenes could be responsible for the antiplasmodial activity.

Financial support and sponsorship

This study was financially supported by the Vice-Rectory for Research at the University of Cartagena (project #098-2018).

Conflicts of interest

There are no conflicts of interest.

References

1Maldonado C, Barnes CJ, Cornett C, Holmfred E, Hansen SH, Persson C, et al. Phylogeny predicts the quantity of antimalarial alkaloids within the iconic yellow cinchona bark (Rubiaceae: Cinchona calisaya). Front Plant Sci 2017;8:391.
2Cruz LR, Spangenberg T, Lacerda MV, Wells TN. Malaria in South America: A drug discovery perspective. Malar J 2013;12:168.
3Staines HM, Burrow R, Teo BH, Chis Ster I, Kremsner PG, Krishna S. Clinical implications of Plasmodium resistance to atovaquone/proguanil: A systematic review and meta-analysis. J Antimicrob Chemother 2018;73:581-95.
4Gómez-Estrada H, Díaz-Castillo F, Franco-Ospina L, Mercado-Camargo J, Guzmán-Ledezma J, Medina JD, et al. Folk medicine in the northern coast of Colombia: An overview. J Ethnobiol Ethnomed 2011;7:27.
5Burrows JN, Burlot E, Campo B, Cherbuin S, Jeanneret S, Leroy D, et al. Antimalarial drug discovery – The path towards eradication. Parasitology 2014;141:128-39.
6Beltrán Villanueva CE, Díaz Castillo F, Gómez Estrada H. Tamizaje fitoquímico preliminar de especies de plantas promisorias de la costa atlántica colombiana. Rev Cubana Plant Med 2013;18:619-31.
7Rodríguez-Cavallo E, Guarnizo-Méndez J, Yépez-Terrill A, Cárdenas-Rivero A, Díaz-Castillo F, Méndez-Cuadro D. Protein carbonylation is a mediator in larvicidal mechanisms of Tabernaemontana cymosa ethanolic extract. J King Saud Univ Sci 2019;31:464-71.
8Muthaura CN, Rukunga GM, Chhabra SC, Omar SA, Guantai AN, Gathirwa JW, et al. Antimalarial activity of some plants traditionally used in treatment of malaria in Kwale district of Kenya. J Ethnopharmacol 2007;112:545-51.
9Radfar A, Méndez D, Moneriz C, Linares M, Marín-García P, Puyet A, et al. Synchronous culture of Plasmodium falciparum at high parasitemia levels. Nat Protoc 2009;4:1899-915.
10Moneriz C, Marín-García P, Bautista JM, Diez A, Puyet A. Haemoglobin interference and increased sensitivity of fluorimetric assays for quantification of low-parasitaemia Plasmodium infected erythrocytes. Malar J 2009;8:279.
11Shuaibu MN, Wuyep PA, Yanagi T, Hirayama K, Tanaka T, Kouno I. The use of microfluorometric method for activity-guided isolation of antiplasmodial compound from plant extracts. Parasitol Res 2008;102:1119-27.
12Strober W. Trypan blue exclusion test of cell viability. Curr Protoc Immunol 2001;21: A.3B.1-A.3B.2.
13Martínez A, Reyes I, Reyes N. Cytotoxicity of the herbicide glyphosate in human peripheral blood mononuclear cells. Biomedica 2007;27:594-604.
14Shiva Shankar Reddy CS, Subramanyam MV, Vani R, Asha Devi S. In vitro models of oxidative stress in rat erythrocytes: Effect of antioxidant supplements. Toxicol In Vitro 2007;21:1355-64.
15Moneriz C, Marín-García P, García-Granados A, Bautista JM, Diez A, Puyet A. Parasitostatic effect of maslinic acid. I. growth arrest of Plasmodium falciparum intraerythrocytic stages. Malar J 2011;10:82.
16Usman H, Abdulrahman F, Usman A. Qualitative phytochemical screening and in vitro antimicrobial effects of methanol stem bark extract of Ficus thonningii (Moraceae). Afr J Tradit Complement Altern Med 2009;6:289-95.
17Berthi W, González A, Rios A, Blair S, Cogollo Á, Pabón A. Anti-plasmodial effect of plant extracts from Picrolemma huberi and Picramnia latifolia. Malar J 2018;17:151.
18Irungu BN, Rukunga GM, Mungai GM, Muthaura CN. In vitro antiplasmodial and cytotoxicity activities of 14 medicinal plants from Kenya. S Afr J Bot 2007;73:204-7.
19Biamonte MA, Wanner J, Le Roch KG. Recent advances in malaria drug discovery. Bioorg Med Chem Lett 2013;23:2829-43.
20Lemma MT, Ahmed AM, Elhady MT, Ngo HT, Vu TL, Sang TK, et al. Medicinal plants for in vitro antiplasmodial activities: A systematic review of literature. Parasitol Int 2017;66:713-20.
21Gupta MP, Santana AI, Espinosa A. Panamá: OEA Publicaciones; 2011.
22Marcotullio MC, Curini M, Becerra JX. An ethnopharmacological, phytochemical and pharmacological review on lignans from Mexican Bursera spp. Molecules 2018;23:E1976.
23Carretero ME, López-Pérez JL, Abad MJ, Bermejo P, Tillet S, Israel A, et al. Preliminary study of the anti-inflammatory activity of hexane extract and fractions from Bursera simaruba (Linneo) Sarg. (Burseraceae) leaves. J Ethnopharmacol 2008;116:11-5.
24Rojas Hernández NM, Rodríguez Uramis M. Antimicrobial activity of tectona grandis L. f., Bursera simaruba (L.) Sarg. and Cedrela odorata L. Rev Cubana Plant Med 2008;13:1-8.
25Bah M, Gutiérrez-Avella DM, Mendoza S, Rodríguez-Lopez V, Castañeda-Moreno R. Chemical constituents and antioxidant activity of extracts obtained from branch bark of Bursera simaruba. Bol Latinoam Caribe Planta Med Aromat 2014; 13:527-36.
26Álvarez ÁL, Habtemariam S, Parra F. Inhibitory effects of lupene-derived pentacyclic triterpenoids from Bursera simaruba on HSV-1 and HSV-2 in vitro replication. Nat Prod Res 2015;29:2322-7.
27Magos-Guerrero GA, Santiago-Mejía J, Carrasco OF. Exploratory studies of some Mexican medicinal plants: Cardiovascular effects in rats with and without hypertension. J Intercult Ethnopharmacol 2017;6:274-9.
28Pereira GA, Peixoto Araujo NM, Arruda HS, Farias DP, Molina G, Pastore GM. Phytochemicals and biological activities of mutamba (Guazuma ulmifolia Lam.): A review. Food Res Int 2019;126:108713.
29Quintana Arias RF. Traditional medicine in the community of San Basilio de Palenque. Nova 2016;14:67-93.
30Kaur D, Kaur A, Arora S. Delineation of attenuation of oxidative stress and mutagenic stress by Murraya exotica L. leaves. Springerplus 2016;5:1037.
31He SD, Yang XT, Yan CC, Jiang Z, Yu SH, Zhou YY, et al. Promising compounds from murraya exotica for cancer metastasis chemoprevention. Integr Cancer Ther 2017;16:556-62.
32Liu BY, Zhang C, Zeng KW, Li J, Guo XY, Zhao MB, et al. Anti-inflammatory prenylated phenylpropenols and coumarin derivatives from murraya exotica. J Nat Prod 2018;81:22-33.
33Forkuo AD, Mensah KB, Ameyaw EO, Antwi AO, Kusi-Boadum NK, Ansah C. Antiplasmodial and antipyretic activity and safety evaluation of the methanolic leaf extract of Murraya exotica (L.). J Parasitol Res 2020;2020:1-8.
34Pitts JF, Barker NH, Gibbons DC, Jay JL. Manchineel keratoconjunctivitis. Br J Ophthalmol 1993;77:284-8.
35Muscat MK. Manchineel apple of death. EJIFCC 2019;30:346-8.
36Tiffert T, Ginsburg H, Krugliak M, Elford BC, Lew VL. Potent antimalarial activity of clotrimazole in in vitro cultures of Plasmodium falciparum. Proc Natl Acad Sci USA 2000;97:331-6.
37Murata T, Miyase T, Muregi FW, Naoshima-Ishibashi Y, Umehara K, Warashina T, et al. Antiplasmodial triterpenoids from Ekebergia capensis. J Nat Prod 2008;71:167-74.
38Berlinck RG, Burtoloso AC, Kossuga MH. The chemistry and biology of organic guanidine derivatives. Nat Prod Rep 2008;25:919-54.